EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Process Development for the Continuous Manufacturing of Carbamazepine-Nicotinamide Co-Crystals Utilizing Hot-Melt Extrusion Technology

Lianghao Huang, Wen Ni, Yaru Jia, Minqing Zhu, Tiantian Yang, Mingchao Yu, Jiaxiang Zhang iD

Pharmaceutics · 25.04.2025 · 17 (5) · 568

DOI: 10.3390/pharmaceutics17050568 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 25.04.2025. Verfasst von Lianghao Huang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Marine Drugs, Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, China. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Taishan Scholar Foundation of Shandong Province, Natural Science Foundation of Qingdao Municipality, Natural Science Foundation of Shandong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Hot-melt extrusion (HME) offers a solvent-free, scalable approach for manufacturing pharmaceutical co-crystals (CCs), aligning with the industry’s shift to continuous manufacturing (CM). However, challenges like undefined yield optimization, insufficient risk management, and limited process analytical technology (PAT) integration hinder its industrial application. This study aimed to develop a proof-of-concept HME platform for CCs, assess process risks, and evaluate PAT-enabled monitoring to facilitate robust production.

Methods

Using carbamazepine (CBZ) and nicotinamide (NIC) as model compounds, an HME platform compatible with PAT tools was established. A systematic risk assessment identified five key risk domains: materials, machinery, measurement, methods, and other factors. A Box–Behnken design of experiments (DoE) evaluated the impact of screw speed, temperature, and mixing sections on CC quality. Near-infrared (NIR) spectroscopy monitored CBZ-NIC co-crystal formation in real time during HME process.

Results

DoE revealed temperature and number of mixing sections significantly influenced particle size (D50: 2.0–4.0 μm), while screw speed affected efficiency. NIR spectroscopy detected a unique CC absorption peak at 5008.3 cm⁻¹, enabling real-time structural monitoring with high accuracy (R² = 0.9999). Risk assessment highlighted material attributes, process parameters, and equipment design as critical factors affecting CC formation. All experimental batches yielded ≥ 94% pure CCs with no residual starting materials, demonstrating process reproducibility and robustness.

Conclusions

Overall, this work successfully established a continuous hot-melt extrusion (HME) process for manufacturing CBZ-NIC co-crystals, offering critical insights into material, equipment, and process parameters while implementing robust in-line NIR monitoring for real-time quality control. Additionally, this work provides interpretable insights and serves as a basis for future machine learning (ML)-driven studies.

Schlagwörter

Stichwörter der Autor:innen

Box–Behnken designco-crystalcontinuous manufacturinghot-melt extrusionprocess analytical technology toolsrisk assessment

Autor:innen und Institutionen

  • Key Laboratory of Marine Drugs, Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, China.
  • Pharmaceutical Products Research and Development Center, Marine Biomedical Research Institute of Qingdao, Qingdao 266137, China.
  • Material Characterization, Thermo Fisher Scientific, Shanghai 201203, China.

ORCID-Profile: Jiaxiang Zhang

Förderung

  • Taishan Scholar Foundation of Shandong Province
  • Natural Science Foundation of Qingdao Municipality
  • Natural Science Foundation of Shandong Province

Zitieren

APA

Huang, L., Ni, W., Jia, Y., Zhu, M., Yang, T., Yu, M., & Zhang, J. (2025). Process Development for the Continuous Manufacturing of Carbamazepine-Nicotinamide Co-Crystals Utilizing Hot-Melt Extrusion Technology. Pharmaceutics, 17(5), 568. https://doi.org/10.3390/pharmaceutics17050568

Vancouver

Huang L, Ni W, Jia Y, Zhu M, Yang T, Yu M, et al. Process Development for the Continuous Manufacturing of Carbamazepine-Nicotinamide Co-Crystals Utilizing Hot-Melt Extrusion Technology. Pharmaceutics. 2025;17(5):568. doi:10.3390/pharmaceutics17050568

BibTeX
@article{Huang2025,
  author = {Huang, Lianghao and Ni, Wen and Jia, Yaru and Zhu, Minqing and Yang, Tiantian and Yu, Mingchao and Zhang, Jiaxiang},
  title = {Process Development for the Continuous Manufacturing of Carbamazepine-Nicotinamide Co-Crystals Utilizing Hot-Melt Extrusion Technology},
  journal = {Pharmaceutics},
  year = {2025},
  volume = {17},
  number = {5},
  pages = {568},
  doi = {10.3390/pharmaceutics17050568}
}
Kostenlos starten →